Xiidra 5% ophthalmic solution single-use vials Images
Generic Name: lifitegrast
This medication has been identified as Xiidra 5% ophthalmic solution single-use vials. It is supplied by Novartis Pharmaceuticals Corporation.
Xiidra is used in the treatment of Dry Eye Disease and belongs to the drug class ophthalmic anti-inflammatory agents. Xiidra 5% ophthalmic solution single-use vials is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Xiidra
- Generic Name
- lifitegrast
- Strength
- 5% ophthalmic solution single-use vials
- Availability
- Prescription only
- Drug Class
- Ophthalmic anti-inflammatory agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0911
More about Xiidra (lifitegrast ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (449)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: ophthalmic anti-inflammatory agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.